UPMC Enterprises Translational Sciences Info Session

Therapeutics Development Funding Opportunity

Wednesday, August 21, 2024, 12 p.m. EST
Virtual

Join Us for the UPMC Enterprises Translational Sciences Info Session on Therapeutics Development Funding Opportunity.

Speakers:

• Anna Mamo, MS, MBA, Director, Translational Sciences
• John Lowman, Manager, Portfolio Development

The University of Pittsburgh is collaborating with UPMC Enterprises Translational Sciences on a request for proposals focused on:

• CENTRAL NERVOUS SYSTEM (CNS)

• • Technologies, approaches, or platforms that improve delivery of next-generation therapeutics to the brain 

• • Disease-modifying therapies for defined patient populations with CNS diseases (including neuropsychiatry but excluding neurovascular, neuro-oncology, and psychedelics) 

• INFLAMMATION AND IMMUNOLOGY

• • Novel tolerization strategies for managing immune-driven conditions (e.g. allergy, autoimmune disease, and transplant rejection) 

• • Novel approaches for targeting memory T cells in immune-driven conditions 

• METABOLIC DISEASE

• • Novel therapeutics or approaches that attenuate inflammation and prevent or reverse pathogenic tissue remodeling in any organ system

Pre-proposals will be accepted on InfoReady until Sep 6, 2024.

A recording of the info session will be made available.

Questions can be directed to Colleen Cassidy (cmc215@pitt.edu) and Sam Musselman (scm66@pitt.edu) with Pitt’s Office of Innovation and Entrepreneurship.

Submit your pre-proposal on Pitt InfoReady today.